Viewing Study NCT06952660


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-01-03 @ 11:05 PM
Study NCT ID: NCT06952660
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module